Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy

Current cancer therapies have encountered adverse response due to poor therapeutic efficiency, severe side effects and acquired resistance to multiple drugs. Thus, there are urgent needs for finding new cancer-targeted pharmacological strategies. In this review, we summarized the current understandi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bin-Bin Li, Bo Wang, Cheng-Ming Zhu, Di Tang, Jun Pang, Jing Zhao, Chun-Hui Sun, Miao-Juan Qiu, Zhi-Rong Qian
Format: article
Langue:EN
Publié: KeAi Communications Co., Ltd. 2019
Sujets:
Accès en ligne:https://doaj.org/article/c65a4a41082d4663a0cc81b8d4f5703e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!